kezar life sciences inc stock

Announced that the Compensation Committee of the companys Board of Directors granted two employees nonqualified stock options to purchase. No recent news for Kezar Life Sciences Inc.

Kezar Life Sciences Crunchbase Company Profile Funding

09 2021 Kezar Life Sciences gets dosing underway in early-stage KZR.

. Kwhen Dec 28 2021. The Kezar Life Sciences Inc stock price fell by -314 on the last day Wednesday 27th Apr 2022 from 1274 to 1234. Find real-time KZR - Kezar Life Sciences Inc stock quotes company profile.

On average they expect. And has now fallen 3 days in a rowDuring the day the. Company profile page for Kezar Life Sciences Inc including stock price company news press releases executives board members and contact information.

Why Kezar Life Sciences Stock Is Soaring Today Nov. KZR stock price quote stock graph. Real time Kezar Life Sciences Inc.

3 equities research analysts have issued twelve-month price objectives for Kezar Life Sciences shares. ET on Motley Fool Kezar Life Sciences KZR Gets a Buy Rating from HC. KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic.

Kezar Life Sciences Inc. Common Stock stock price and ETFs. SEC Filing - Quarterly Report 10-Q November 09 2021 SEC Filings Tue Nov.

News Kezar Life Sciences IncKZR. 4000 Shoreline Court Suite 300 South San Francisco CA 94080. The company has a debt-to-equity ratio of 005 a current ratio of 2577 and a quick ratio of 2577.

The Price to Earnings PE ratio a key valuation measure is calculated by dividing the stocks most. Kezar Life Sciences Inc. 4000 Shoreline Court Suite 300 South San Francisco CA 94080 T.

16 2021 at 1138 am. Kezar Life Sciences Inc. As of May 05 2022 Kezar Life Sciences Inc had a 4204 million market capitalization compared to the Biotechnology.

Is a clinical-stage biopharmaceutical company. Primary metrics and data points about Kezar Life Sciences Inc. The firm has a.

Has filed a 13G form with the Securities and Exchange Commission SEC disclosing ownership of 2871244 shares of Kezar Life Sciences Inc KZRKZR. The Company is engaged in developing novel small molecule therapeutics to treat autoimmune. KZR a clinical-stage biotechnology company discovering and developing.

Finally HC Wainwright upped their price target on Kezar Life Sciences from 2000 to 2200 and gave the stock a buy rating in a report on Friday March 18th. Their forecasts range from 1400 to 2200. Latest Kezar Life Sciences Inc KZR Stock News.

Get Kezar Life Sciences Inc KZRNASDAQ real-time stock quotes news price and financial information from CNBC. Kezar Life Sciences Inc. No significant news for KZR in the past two years.

SOUTH SAN FRANCISCO Calif--BUSINESS WIRE-- Kezar Life Sciences Inc Nasdaq. Kezar Life Sciences Inc. Kezar Life Sciences Inc Shares Near 52-Week High - Market Mover.

View KZR predictions and other driverless cars portfolios. Kezar Life Sciences Inc Nasdaq. Shares of Kezar Life Sciences stock opened at 645 on Friday.

Kezar Life Sciences Announces Pricing Of Initial Public Offering